- Home
- ETON vs CRNC Comparison
ETON vs CRNC Comparison
Compare ETON & CRNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- CRNC
- Stock Information
- Founded
- ETON 2017
- CRNC 2020
- Country
- ETON United States
- CRNC United States
- Employees
- ETON N/A
- CRNC N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- CRNC EDP Services
- Sector
- ETON Health Care
- CRNC Technology
- Exchange
- ETON Nasdaq
- CRNC Nasdaq
- Market Cap
- ETON 388.3M
- CRNC 418.7M
- IPO Year
- ETON 2018
- CRNC N/A
- Fundamental
- Price
- ETON $14.85
- CRNC $9.37
- Analyst Decision
- ETON Strong Buy
- CRNC Buy
- Analyst Count
- ETON 3
- CRNC 7
- Target Price
- ETON $29.67
- CRNC $9.43
- AVG Volume (30 Days)
- ETON 636.4K
- CRNC 2.1M
- Earning Date
- ETON 08-07-2025
- CRNC 08-07-2025
- Dividend Yield
- ETON N/A
- CRNC N/A
- EPS Growth
- ETON N/A
- CRNC N/A
- EPS
- ETON N/A
- CRNC N/A
- Revenue
- ETON $48,327,000.00
- CRNC $254,250,000.00
- Revenue This Year
- ETON $103.21
- CRNC N/A
- Revenue Next Year
- ETON $51.34
- CRNC $8.02
- P/E Ratio
- ETON N/A
- CRNC N/A
- Revenue Growth
- ETON 40.88
- CRNC N/A
- 52 Week Low
- ETON $3.25
- CRNC $2.34
- 52 Week High
- ETON $21.48
- CRNC $27.50
- Technical
- Relative Strength Index (RSI)
- ETON 54.31
- CRNC 48.26
- Support Level
- ETON $13.78
- CRNC $9.28
- Resistance Level
- ETON $16.27
- CRNC $11.92
- Average True Range (ATR)
- ETON 0.83
- CRNC 0.87
- MACD
- ETON 0.32
- CRNC -0.01
- Stochastic Oscillator
- ETON 77.67
- CRNC 35.06
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.